Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Cathelicidin LL-37 is one of the few human bactericidal peptides with potent antistaphylococcal activity. In this study we examined the susceptibility of LL-37 to proteolytic degradation by two major proteinases produced by Staphylococcus aureus , a metalloproteinase (aureolysin) and a glutamylendopeptidase (V8 protease). We found that aureolysin cleaved and inactivated LL-37 in a time- and concentration-dependent manner. Analysis of the generated fragments by mass spectroscopy revealed that the initial cleavage of LL-37 by aureolysin occurred between the Arg19-Ile20, Arg23-Ile24, and Leu31-Val32 peptide bonds, instantly annihilating the antibacterial activity of LL-37. In contrast, the V8 proteinase hydrolyzed efficiently only the Glu16-Phe17 peptide bond, rendering the C-terminal fragment refractory to further degradation. This fragment (termed LL-17-37) displayed antibacterial activity against S. aureus at a molar level similar to that of the full-length LL-37 peptide, indicating that the antibacterial activity of LL-37 resides in the C-terminal region. In keeping with LL-37 degradation by aureolysin, S. aureus strains that produce significant amounts of this metalloprotease were found to be less susceptible to LL-17-37 than strains expressing no aureolysin activity. Taken together, these data suggest that aureolysin production by S. aureus contributes to the resistance of this pathogen to the innate immune system of humans mediated by LL-37.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595 · cited 1×
“Nasal carriage is an important risk factor for serious systemic and internal organ infections that have high morbidity and mortality, especially in those patients with a suppressed immune system, undergoing surgery, or with intravenous devices (18).”
BackgroundEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960 · cited 1×
“... the following observations: the mouse cathelicidin CRAMP protects the skin from invasive bacterial infections (27); proteolytic processing of porcine cathelicidins (protegrins) is essential for bacterial clearance from wounds (9); improved lung clearance of Pseudomonas aeruginosa is associated with overexpression…”
BackgroundIsolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Killing activity of neutrophils is mediated through activation of proteases by K+ flux
Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G. M., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., & Segal, A. W. (2002) · Nature · doi:10.1038/416291a · Cited by 1,153 · cited 2×
“Oxygen-independent killing mechanisms mediated by antimicrobial peptides or proteins ( 34 , 39) play a more important role in killing staphylococci than previously thought.”
BackgroundPeschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988 · cited 1×
“Because the expression of aureolysin is negatively regulated (8, 48) by the product of the staphylococcal accessory regulator gene (sarA), we used mutants of strains Newman and SH1000 deficient in this regulator.”
MethodSørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
Frohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Lidén, S., Wigzell, H., & Gudmundsson, G. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15258 · Cited by 803
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Dermcidin: A novel human antibiotic peptide secreted by sweat glands
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., Schroeder, K., Blin, N., Meier, F., et al. (2001) · Nature Immunology · doi:10.1038/ni732 · Cited by 730
Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K., & Foster, S. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5457-5467.2002 · Cited by 699
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis
Belaaouaj, A., McCarthy, R., Baumann, M., Gao, Z., Ley, T. J., Abraham, S. N., & Shapiro, S. D. (1998) · Nature Medicine · doi:10.1038/nm0598-615 · Cited by 691
Ultrasensitive assays for endogenous antimicrobial polypeptides
Lehrer, R. I., Rosenman, M., Harwig, S. S. S. L., Jackson, R., & Eisenhauer, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90021-7 · Cited by 671
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., & Gudmundsson, G. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.195 · Cited by 503
How do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
Antimicrobial peptides in animals and their role in host defences
Brogden, K. A., Ackermann, M., McCray, P. B., & Tack, B. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00180-8 · Cited by 458
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
Tkalcevic, J., Novelli, M., Phylactides, M., Iredale, J. P., Segal, A. W., & Roes, J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80173-9 · Cited by 383
Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides
Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Lehrer, R. I., Welsh, M. J., & Tack, B. F. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2748-2755.2000 · Cited by 369
Sørensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., & Borregaard, N. (1997) · Blood · doi:10.1182/blood.v90.7.2796 · Cited by 365
Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., & Tarkowski, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1169 · Cited by 319
Self-citationPostsecretory Processing Generates Multiple Cathelicidins for Enhanced Topical Antimicrobial Defense
Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., & Gallo, R. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3070 · Cited by 308
Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide
Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., & Wilson, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6084-6089.1999 · Cited by 302
Chan, P. F., & Foster, S. J. (1998) · Journal of Bacteriology · doi:10.1128/.180.23.6232-6241.1998 · Cited by 253
[38] Protease from Staphyloccus aureus
Drapeau, G. R. (1976) · Methods in Enzymology · doi:10.1016/s0076-6879(76)45041-3 · Cited by 251
The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
Walsh, T. R., & Howe, R. A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160806 · Cited by 215
Extracellular proteins ofStaphylococcus aureus and the role of SarA andσB
Ziebandt, A.-K., Weber, H., Rudolph, J., Schmid, R., Höper, D., Engelmann, S., & Hecker, M. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200104)1:4<480::aid-prot480>3.0.co;2-o · Cited by 196
Bals, R., Weiner, D. J., Meegalla, R. L., & Wilson, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6570 · Cited by 190
Cathelicidin family of antimicrobial peptides: Proteolytic processing and protease resistance
Shinnar, A. E., Butler, K. L., & Park, H. J. (2003) · Bioorganic Chemistry · doi:10.1016/s0045-2068(03)00080-4 · Cited by 170
Panyutich, A., Shi, J., Boutz, P. L., Zhao, C., & Ganz, T. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.978-985.1997 · Cited by 153
McAleese, F. M., Walsh, E. J., Sieprawska, M., Potempa, J., & Foster, T. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102389200 · Cited by 153
Self-citationSCOCCHI, M., SKERLAVAJ, B., ROMEO, D., & GENNARO, R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17324.x · Cited by 149
Cole, A. M., Shi, J., Ceccarelli, A., Kim, Y.-H., Park, A., & Ganz, T. (2001) · Blood · doi:10.1182/blood.v97.1.297 · Cited by 146
Chronic granulomatous disease in adults
Liese, J. G., Jansson, A. F., Petropoulou, T., Kloos, S., Belohradsky, B. H., Jendrossek, V., & Gahr, M. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90403-1 · Cited by 145
Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin
Peschel, A., & Collins, L. V. (2001) · Peptides · doi:10.1016/s0196-9781(01)00500-9 · Cited by 119
Juretić, D., Chen, H., Brown, J. H., Morell, J. L., Hendler, R. W., & Westerhoff, H. V. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80627-1 · Cited by 84
Shafer, W. M., Pohl, J., Onunka, V. C., Bangalore, N., & Travis, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52409-1 · Cited by 79
Self-citationMolecular Cloning and Biochemical Characterisation of Proteases from Staphylococcus epidermidis
Dubin, G., Chmiel, D., Mak, P., Rakwalska, M., Rzychon, M., & Dubin, A. (2001) · Biological Chemistry · doi:10.1515/bc.2001.192 · Cited by 79
Zucht, H.-D., Grabowsky, J., Schrader, M., Liepke, C., Jürgens, M., Schulz‐Knappe, P., & Forssmann, W. G. (1998) · PubMed · Cited by 79
Shafer, W. M., Hubálek, F., Huang, M. R., & Pohl, J. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4842-4845.1996 · Cited by 55
Self-citationMoon, J. L., Banbula, A., Oleksy, A., Mayo, J. A., & Travis, J. W. (2001) · Biological Chemistry · doi:10.1515/bc.2001.138 · Cited by 40
Self-citation
Cited by
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808
“…species may share a mutualistic or commensal relationship to enhance common resistance to antimicrobial peptides (Peschel et al. 2001; Sieprawska-Lupa et al. 2004; Lai et al. 2007; Li et al. 2007) or enhance binding to exposed extracellular matrix proteins in inflamed AD skin…”
BackgroundBahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
Self-citation
Metadata
- Authors
- Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., Shafer, W., McAleese, F., Foster, T., Travis, J., & Potempa, J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-12
- Volume
- 48
- Issue
- 12
- Pages
- 4673-4679
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2098786490
- Cited by
- 551
- References
- 49
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.